Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
18 July 2019 | Story Ruan Bruwer
Gauta Mokati
The men’s football team from the University of the Free State will be captained by Gauta Mokati. He led the South African Student team at last year’s CUCSA (Confederation of University and College Sports Association) Games.
The coach of the men’s football team is hoping that their ability to adapt to a new game plan, if required, will stand them in good stead during the upcoming Varsity Football tournament.

The Kovsies are back in Varsity Football after five years, thanks to their performance at last year’s USSA championship where they finished sixth.

They will feature in the opening match on 25 July 2019, a fixture played at Shimla Park that will be broadcast live on SuperSport.

“In the Free State Motsepe Cup, we were one of the youngest teams. Now we intend to use the experience we have gained to benefit us in the Varsity Football competition. We can play a physical game and a technical game, as well as a combination of both,” said coach Godfrey Tenoff.

“We had a lot of high-pressure matches in the past two years to prepare us. Although the team is young, they have actually been exposed through various competitions.”

The UFS team received a favourable draw, playing four of their seven matches at home. Two of those opponents, the Tshwane University of Technology (22 August) and the University of Johannesburg (29 August), made last year’s semi-final. The UFS have a score to settle with UJ, who knocked them out in the semi-final in 2014.

“We need to give the crowd something to believe in. Once the crowd see the intent and passion, they can rally behind us. The most important thing is to play with confidence for each other, for the team, and for the badge. The crowd will appreciate that.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept